Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  O'Dwyer, Laurence ^a   Lamberton, Franck ^b   Matura, Silke ^a   Tanner, Colby ^c   Scheibe, Monika ^a   Miller, Julia ^a   Rujescu, Dan ^d   Prvulovic, David ^a   Hampel, Harald ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITÉ DE CAEN   (France)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AMYGDALOID NUCLEUS; APOLIPOPROTEIN 4 GENE; ARTICLE; BRAIN RADIOGRAPHY; BRAIN SIZE; BRAIN STEM; CAUDATE NUCLEUS; COGNITION; EDUCATIONAL STATUS; FEMALE; GENE; GENOTYPE; GLOBUS PALLIDUS; GRAY MATTER; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; IMAGE PROCESSING; LEFT HEMISPHERE; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PUTAMEN; QUANTITATIVE ANALYSIS; RIGHT HEMISPHERE; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ANALYSIS; THALAMUS;

ADULT; APOLIPOPROTEIN E4; ATROPHY; BRAIN; FEMALE; HETEROZYGOTE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; YOUNG ADULT;

EID: 84869074295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048895     Document Type: Article

References (92)

1. Beffert U, Stolt PC, Herz J, (2004) Functions of lipoprotein receptors in neurons. J Lipid Res 45: 403-409 doi:10.1194/jlr.R300017-JLR200.
2. Beffert U, Nematollah Farsian F, Masiulis I, Hammer RE, Yoon SO, et al. (2006) ApoE receptor 2 controls neuronal survival in the adult brain. Curr Biol 16: 2446-2452 doi:10.1016/j.cub.2006.10.029.
3. Finch CE, Sapolsky RM, (1999) The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging 20: 407-428.
4. Verghese PB, Castellano JM, Holtzman DM, (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. The Lancet Neurology 10: 241-252 doi:10.1016/S1474-4422(10)70325-2.
5. Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, et al. (1982) Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 23: 911-914.
6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
7. Okuizumi K, Onodera O, Tanaka H, Kobayashi H, Tsuji S, et al. (1994) ApoE-epsilon 4 and early-onset Alzheimer's. Nat Genet 7: 10-11 doi:10.1038/ng0594-10b.
8. Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, et al. (1995) Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 67: 65-72.
9. Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, et al. (2009) Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage 44: 724-728 doi:10.1016/j.neuroimage.2008.10.003.
10. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, et al. (2000) Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343: 450-456 doi:10.1056/NEJM200008173430701.
11. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, et al. (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U.S.A 97: 6037-6042 doi:10.1073/pnas.090106797.
12. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, et al. (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 101: 284-289 doi:10.1073/pnas.2635903100.
13. Bondi MW, Houston WS, Eyler LT, Brown GG, (2005) fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64: 501-508 doi:10.1212/01.WNL.0000150885.00929.7E.
14. Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, et al. (2006) Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 67: 1221-1224 doi:10.1212/01.wnl.0000238079.00472.3a.
15. Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, et al. (1999) Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52: 91-100.
16. Du A-T, Schuff N, Chao LL, Kornak J, Jagust WJ, et al. (2006) Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging 27: 733-740 doi:10.1016/j.neurobiolaging.2005.03.021.
17. Barboriak DP, Doraiswamy PM, Krishnan KR, Vidyarthi S, Sylvester J, et al. (2000) Hippocampal sulcal cavities on MRI: relationship to age and apolipoprotein E genotype. Neurology 54: 2150-2153.
18. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, et al. (2002) Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 59: 746-748.
19. Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, et al. (2007) Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. The Lancet Neurology 6: 494-500 doi:10.1016/S1474-4422(07)70106-0.
20. Burggren AC, Zeineh MM, Ekstrom AD, Braskie MN, Thompson PM, et al. (2008) Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 41: 1177-1183 doi:10.1016/j.neuroimage.2008.03.039.
21. Schmidt H, Schmidt R, Fazekas F, Semmler J, Kapeller P, et al. (1996) Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet 50: 293-299.
22. Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, et al. (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 44: 288-291 doi:10.1002/ana.410440226.
23. Cherbuin N, Anstey KJ, Sachdev PS, Maller JJ, Meslin C, et al. (2008) Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. J Gerontol A Biol Sci Med Sci 63: 501-504.
24. Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, et al. (2008) APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 70: 1842-1849 doi:10.1212/01.wnl.0000304038.37421.cc.
25. Lind J, Persson J, Ingvar M, Larsson A, Cruts M, et al. (2006) Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 129: 1240-1248 doi:10.1093/brain/awl054.
26. Mondadori CRA, de Quervain DJ-F, Buchmann A, Mustovic H, Wollmer MA, et al. (2007) Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 17: 1934-1947 doi:10.1093/cercor/bhl103.
27. Filbey FM, Slack KJ, Sunderland TP, Cohen RM, (2006) Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 17: 1585-1590 doi:10.1097/01.wnr.0000234745.27571.d1.
28. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, et al. (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA 106: 7209-7214 doi:10.1073/pnas.0811879106.
29. Dennis NA, Browndyke JN, Stokes J, Need A, Burke JR, et al. (2010) Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement 6: 303-311 doi:10.1016/j.jalz.2009.07.003.
30. Liu F, Pardo LM, Schuur M, Sanchez-Juan P, Isaacs A, et al. (2010) The apolipoprotein E gene and its age-specific effects on cognitive function. Neurobiol Aging 31: 1831-1833 doi:10.1016/j.neurobiolaging.2008.09.015.
31. Marchant NL, King SL, Tabet N, Rusted JM, (2010) Positive Effects of Cholinergic Stimulation Favor Young APOE ε4 Carriers. Neuropsychopharmacology 35: 1090-1096 doi:10.1038/npp.2009.214.
32. Han SD, Bondi MW, (2008) Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 4: 251-254 doi:10.1016/j.jalz.2008.02.006.
33. Tuminello ER, Han SD, (2011) The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations. Int J Alzheimers Dis 2011: 726197 doi:10.4061/2011/726197.
34. Mueller SG, Weiner MW, (2009) Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus 19: 558-564 doi:10.1002/hipo.20614.
35. Jak AJ, Houston WS, Nagel BJ, Corey-Bloom J, Bondi MW, (2007) Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord 23: 382-389 doi:10.1159/000101340.
36. Pedraza O, Bowers D, Gilmore R, (2004) Asymmetry of the hippocampus and amygdala in MRI volumetric measurements of normal adults. J Int Neuropsychol Soc 10: 664-678 doi:10.1017/S1355617704105080.
37. Soininen H, Partanen K, Pitkänen A, Hallikainen M, Hänninen T, et al. (1995) Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology 45: 391-392.
38. Tohgi H, Takahashi S, Kato E, Homma A, Niina R, et al. (1997) Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett 236: 21-24.
39. Geroldi C, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, et al. (2000) Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatr 68: 93-96.
40. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, et al. (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62: 685-691 doi:10.1001/archpsyc.62.6.685.
41. Lu PH, Thompson PM, Leow A, Lee GJ, Lee A, et al. (2011) Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis 23: 433-442 doi:10.3233/JAD-2010-101398.
42. Patenaude B, Smith SM, Kennedy DN, Jenkinson M, (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56: 907-922 doi:10.1016/j.neuroimage.2011.02.046.
43. Oldfield RC, (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113.
44. Delis DC, Kramer JH, Kaplan E, Ober BA (1987) California Verbal Learning Test: Adult version. San Antonio, Texas: Psychological Corporation.
45. Niemann H, Sturm W, Thone-Otto AIT, Willmes K (2008) California Verbal Learning Test (CVLT). Deutsche adaptation. Frankfurt: Pearson Clinical & Talent Assessment.
46. Benedict R (1997) BriefVisuospatial Memory Test-Revised professional manual. Odessa, FL: Psychological Assessment Resources, Inc.
47. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR, (1997) Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 54: 159-165.
48. Wechsler D (1997) WMS-III administration and scoring manual. San Antonio: The Psychological Corporation.
49. Lehrl S (1995) Mehrfachwahl-Wortschatz-Test (MWT-B). Erlangen: Straube.
50. Beck AT, Steer RA, Brown GK (1996) Beck Depression Inventory. Second ed. San Antonio, Texas: The Psychological Corporation.
51. Hautzinger M, Keller F, Kuhner C (2006) "BDI II" Beck Depressions-Inventar. Second ed. Frankfurt: Harcourt Test Services.
52. Smith SM, De Stefano N, Jenkinson M, Matthews PM, (2001) Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 25: 466-475.
53. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, et al. (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17: 479-489.
54. Jenkinson M, Smith S, (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156.
55. Jenkinson M, Bannister P, Brady M, Smith S, (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17: 825-841.
56. Zhang Y, Brady M, Smith S, (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57 doi:10.1109/42.906424.
57. Bates D, Maechler M, Bolker B (2011) lme4: Linear Mixed-Effects Models Using S4 Classes. Available: http://CRAN.R-project.org/package=lme4.
58. R Development Core Team (2010) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available: http://www.R-project.org.
59. Graham MH, (2003) Confronting multicollinearity in ecologocial multiple regression. Ecology 84: 2809-2815 doi:10.1890/02-3114.
60. O'Dwyer L, Lamberton F, Bokde ALW, Ewers M, Faluyi YO, et al. (2011) Using Diffusion Tensor Imaging and Mixed-Effects Models to Investigate Primary and Secondary White Matter Degeneration in Alzheimer's Disease and Mild Cognitive Impairment. J Alzheimers Dis Available: http://www.ncbi.nlm.nih.gov/pubmed/21694456. Accessed 2011 Jun 25.
61. Anderson DR, Burnham KP (2002) Model selection and multimodel inference: a practical information-theoretic approach. 2nd ed. New York, New YorkUSA: Springer-Verlag.
62. Akaike H, (1979) A Bayesian extension of the minimum AIC procedure of autoregressive model fitting. Biometrika 66: 237-242 doi:10.1093/biomet/66.2.237.
63. Crawley MJ (2007) The R Book. Available: http://onlinelibrary.wiley.com/book/10.1002/9780470515075. Accessed 2012 Aug 31.
64. Lehtovirta M, Soininen H, Laakso MP, Partanen K, Helisalmi S, et al. (1996) SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. J Neurol Neurosurg Psychiatr 60: 644-649.
65. Geroldi C, Pihlajamäki M, Laakso MP, DeCarli C, Beltramello A, et al. (1999) APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53: 1825-1832.
66. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, et al. (2001) Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 57: 1461-1466.
67. Mori E, Lee K, Yasuda M, Hashimoto M, Kazui H, et al. (2002) Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol 51: 209-214.
68. Alexopoulos P, Richter-Schmidinger T, Horn M, Maus S, Reichel M, et al. (2011) Hippocampal Volume Differences Between Healthy Young Apolipoprotein E ε2 and ε4 Carriers. Journal of Alzheimer's Disease 26: 207-210 doi:10.3233/JAD-2011-110356.
69. Sidiropoulos C, Jafari-Khouzani K, Soltanian-Zadeh H, Mitsias P, Alexopoulos P, et al. (2011) Influence of brain-derived neurotrophic factor and apolipoprotein E genetic variants on hemispheric and lateral ventricular volume of young healthy adults. Acta Neuropsychiatr 23: 132-138 doi:10.1111/j.1601-5215.2011.00546.x.
70. Richter-Schmidinger T, Alexopoulos P, Horn M, Maus S, Reichel M, et al. (2011) Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J Neural Transm 118: 249-257 doi:10.1007/s00702-010-0539-8.
71. Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, et al. (1994) Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 343: 1565.
72. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, et al. (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272: 1666-1671.
73. Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, et al. (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6: 29-32 doi:10.1038/ng0194-29.
74. Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, et al. (2009) ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci 29: 15317-15322 doi:10.1523/JNEUROSCI.4026-09.2009.
75. Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M, et al. (2008) Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem 41: 932-936 doi:10.1016/j.clinbiochem.2008.05.001.
76. O'Dwyer L, Lamberton F, Matura S, Scheibe M, Miller J, et al. (2012) White Matter Differences between Healthy Young ApoE4 Carriers and Non-Carriers Identified with Tractography and Support Vector Machines. PLoS ONE 7: e36024 doi:10.1371/journal.pone.0036024.
77. Scarmeas N, Habeck CG, Hilton J, Anderson KE, Flynn J, et al. (2005) APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatr 76: 1440-1444 doi:10.1136/jnnp.2004.053645.
78. Hedden T, Gabrieli JDE, (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5: 87-96 doi:10.1038/nrn1323.
79. Minati L, Edginton T, Bruzzone MG, Giaccone G, (2009) Current concepts in Alzheimer's disease: a multidisciplinary review. Am J Alzheimers Dis Other Demen 24: 95-121 doi:10.1177/1533317508328602.
80. Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, et al. (1997) Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 48: 985-989.
81. Lemaître H, Crivello F, Dufouil C, Grassiot B, Tzourio C, et al. (2005) No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24: 1205-1213 doi:10.1016/j.neuroimage.2004.10.016.
82. Bigler ED, Lowry CM, Anderson CV, Johnson SC, Terry J, et al. (2000) Dementia, quantitative neuroimaging, and apolipoprotein E genotype. AJNR Am J Neuroradiol 21: 1857-1868.
83. Cabeza R, (2002) Hemispheric asymmetry reduction in older adults: the HAROLD model. Psychol Aging 17: 85-100.
84. Bartrés-Faz D, Serra-Grabulosa JM, Sun FT, Solé-Padullés C, Rami L, et al. (2008) Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE epsilon4 allele. Neurobiol Aging 29: 1644-1653 doi:10.1016/j.neurobiolaging.2007.04.021.
85. Trivedi MA, Schmitz TW, Ries ML, Hess TM, Fitzgerald ME, et al. (2008) fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease. Neuropsychologia 46: 1667-1678 doi:10.1016/j.neuropsychologia.2007.11.035.
86. Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, et al. (2009) Semantic memory activation in amnestic mild cognitive impairment. Brain 132: 2068-2078 doi:10.1093/brain/awp157.
87. Filbey FM, Chen G, Sunderland T, Cohen RM, (2010) Failing compensatory mechanisms during working memory in older apolipoprotein E-epsilon4 healthy adults. Brain Imaging Behav 4: 177-188 doi:10.1007/s11682-010-9097-9.
88. Kukolja J, Thiel CM, Eggermann T, Zerres K, Fink GR, (2010) Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience 168: 487-497 doi:10.1016/j.neuroscience.2010.03.044.
89. Seidenberg M, Guidotti L, Nielson KA, Woodard JL, Durgerian S, et al. (2009) Semantic memory activation in individuals at risk for developing Alzheimer disease. Neurology 73: 612-620 doi:10.1212/WNL.0b013e3181b389ad.
90. Schiepers OJG, Harris SE, Gow AJ, Pattie A, Brett CE, et al. (2011) APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921. Mol Psychiatry Available: http://www.ncbi.nlm.nih.gov/pubmed/21263443. Accessed 2 Feb 2012.
91. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, et al. (2009) Longitudinal Growth Modeling of Cognitive Aging and the APOE e4 Effect. N Engl J Med 361: 255-263 doi:10.1056/NEJMoa0809437.
92. Frisoni GB, Whitwell JL, (2008) How fast will it go, doc? New tools for an old question from patients with Alzheimer disease. Neurology 70: 2194-2195 doi:10.1212/01.wnl.0000313844.18381.a9.